Krsnaa Diagnostics Ltd
Krsnaa Diagnostics Ltd provides a range of technology-enabled diagnostic services such as imaging, clinical laboratory, and teleradiology services to hospitals, medical colleges, and community health centers across India with an extensive network across non-metro and lower-tier cities and towns.[1]
- Market Cap ₹ 2,411 Cr.
- Current Price ₹ 742
- High / Low ₹ 970 / 626
- Stock P/E 28.5
- Book Value ₹ 285
- Dividend Yield 0.37 %
- ROCE 11.9 %
- ROE 8.76 %
- Face Value ₹ 5.00
Pros
Cons
- Stock is trading at 2.61 times its book value
- Promoter holding is low: 27.1%
- Company has a low return on equity of 8.27% over last 3 years.
- Debtor days have increased from 100.0 to 141 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Part of BSE Healthcare BSE SmallCap BSE Allcap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|
| 39 | 61 | 455 | 487 | 620 | 717 | 760 | |
| 30 | 42 | 324 | 365 | 475 | 527 | 551 | |
| Operating Profit | 9 | 19 | 132 | 122 | 144 | 190 | 209 |
| OPM % | 23% | 31% | 29% | 25% | 23% | 27% | 27% |
| 3 | 2 | 15 | 19 | 17 | 26 | 22 | |
| Interest | 9 | 9 | 18 | 8 | 16 | 25 | 27 |
| Depreciation | 6 | 12 | 41 | 54 | 75 | 88 | 90 |
| Profit before tax | -3 | 0 | 87 | 80 | 70 | 103 | 113 |
| Tax % | 49% | 180% | 21% | 23% | 19% | 24% | |
| -5 | -0 | 68 | 62 | 57 | 78 | 85 | |
| EPS in Rs | -9.53 | -0.14 | 21.78 | 19.78 | 17.60 | 24.04 | 26.12 |
| Dividend Payout % | 0% | 0% | 11% | 14% | 14% | 11% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 16% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 3% |
| TTM: | 22% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 16% |
| 1 Year: | -21% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 8% |
| Last Year: | 9% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 16 | 16 | 16 | 16 | 16 |
| Reserves | 6 | 6 | 669 | 723 | 794 | 867 | 907 |
| 131 | 102 | 41 | 32 | 160 | 204 | 286 | |
| 44 | 80 | 150 | 137 | 201 | 192 | 298 | |
| Total Liabilities | 186 | 192 | 875 | 908 | 1,170 | 1,278 | 1,507 |
| 74 | 131 | 386 | 471 | 647 | 670 | 683 | |
| CWIP | 20 | 6 | 28 | 25 | 10 | 3 | 30 |
| Investments | 1 | 1 | 0 | 0 | 0 | 32 | 32 |
| 91 | 55 | 461 | 412 | 513 | 573 | 762 | |
| Total Assets | 186 | 192 | 875 | 908 | 1,170 | 1,278 | 1,507 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| -23 | 64 | 128 | 76 | 24 | 87 | |
| -47 | -54 | -241 | -109 | -129 | -100 | |
| 105 | -41 | 176 | -33 | 84 | 14 | |
| Net Cash Flow | 36 | -31 | 64 | -66 | -20 | 1 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2016 | Mar 2017 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Debtor Days | 79 | 84 | 46 | 55 | 104 | 141 |
| Inventory Days | 21 | 24 | ||||
| Days Payable | 76 | 100 | ||||
| Cash Conversion Cycle | 24 | 8 | 46 | 55 | 104 | 141 |
| Working Capital Days | -69 | -113 | -23 | 11 | -21 | 21 |
| ROCE % | 7% | 12% | 10% | 12% |
Documents
Announcements
-
Board Meeting Outcome for For Meeting Held On December 12, 2025.
12 Dec - Board approved private placement of up to INR 430 crore secured NCDs, 7-year tenor, redemption in 13 instalments.
-
Closure of Trading Window
9 Dec - Trading window closed Dec 10 until 48 hours after Dec 12 board meeting on proposed private placement of unlisted NCDs.
-
Board Meeting Intimation for Proposed Fund Raising.
9 Dec - Board meeting on Dec 12, 2025 to consider issuance of unlisted NCDs.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
3 Dec - -Analyst / Institutional Investor Meeting scheduled to be held on December 04, 2025.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
26 Nov - Krsnaa Diagnostics analyst meeting with Athena Investments in Mumbai on Nov 27, 2025, 12:00 IST, physical.
Annual reports
Concalls
-
Nov 2025Transcript PPT REC
-
Nov 2025TranscriptAI SummaryPPT
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Oct 2024TranscriptAI SummaryPPT
-
Aug 2024Transcript PPT
-
Aug 2024TranscriptAI SummaryPPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT REC
-
Jun 2022Transcript PPT
-
Mar 2022TranscriptAI SummaryPPT
-
Feb 2022Transcript PPT
-
Nov 2021TranscriptPPT
-
Oct 2021Transcript PPT
Business Profile[1]
Krsnaa Diagnostics Limited is one of India’s largest differentiated diagnostic service providers with a Pan-India presence in Radiology and Pathology. It has established a Pan India presence through partnerships with government hospitals and operates a substantial number of CT and MRI centers.